Sidley Austin represented Roche in the transaction, and Cooley represented Poseida Therapeutics. Roche, one of the world’s largest biotechnology companies and the global leader in in-vitro...
Roche’s $1.5 Billion Acquisition of Poseida Therapeutics
Radiology Partners’ $720 Million Equity Investment
Sidley Austin and Kirkland & Ellis served as legal counsel to Radiology Partners in the transaction, and Gibson Dunn served as legal to certain RP lenders....
DaVita’s Expansion of its International Operations
Sidley Austin is representing DaVita, Inc. in the deal, and Cleary Gottlieb is representing Fresenius. DaVita Inc (NYSE: DVA), a leading provider of kidney care services,...
Qoo10’s $173 Million Acquisition of Wish
Shearman & Sterlin represented Qoo10 Pte. Ltd. in the transaction, and Sidley Austin represented ContextLogic Inc. ContextLogic Inc. (d/b/a?Wish) (NASDAQ: WISH) (“ContextLogic” or the “Company”) announced...
Flex’s Spin-Off of Nextracker
Sidley Austin represented Flex Ltd. in the deal. Flex Ltd. (Nasdaq: FLEX) announced its spinoff of its remaining interests in Nextracker Inc. (Nasdaq: NXT) to Flex shareholders...
Nextracker’s $662.5 Million Common Stock Offering
Sidley and Davis Polk represented Flex and its subsidiary Nextracker in the offering, Wilson Sonsini represented the underwriters. Nextracker Inc. announced that it priced its combined...
Nextracker’s Initial Public Offering
Wilson Sonsini represented underwriters on the deal while Sidley represented Flex Ltd. and Nextracker Inc. Flex Ltd. announced that its subsidiary, Nextracker Inc., priced its upsized...
Roche’s $1.8 Billion Acquisition of GenMark Diagnostics
Sidley Austin LLP and DLA Piper LLP advised Roche on the deal. Roche (SIX: RO, ROG; OTCQX: RHHBY) and GenMark Diagnostics (NASDAQ: GNMK) announced that they have...